| Welcome and introductions. | 0:17 |
| Health-related quality of life issues for patients with vasculitis. | 5:35 |
| Impact on Women: Four dimensions. | 8:07 |
| Treatment of ANCA-Associated Vasculitis | 8:24 |
| Fertility and Cyclophosphamide. | 10:49 |
| The Effect of Vasculitis on Pregnancy | 13:33 |
| Pregnancy and Treatment. | 18:02 |
| Pregnancy and Biologics. | 19:24 |
| Pregnancy Tips. | 20:23 |
| Menopause and Cyclophosphamide | 21:44 |
| Menopause Tips. | 25:53 |
| Sexuality in Rheumatic Diseases | 26:28 |
| Sexual Dysfuction and Behcet’s Disease. | 28:42 |
| Vascular Impairment and Sexual Dysfunction. | 29:43 |
| Summary of key points on fertility and vasculitis. | 31:10 |
| Q&A: I no longer have monthly bloods taken because my numbers for ANCA don’t spike. Should I be concerned that I’m not being monitored? | 32:48 |
| Q&A: Is it common to feel extremely hot and overheated when I exercise. Is this common with vasculitis? | 35:04 |
| Q&A: How can EGPA affect menopause? | 37:29 |
| Q&A: Do you know what the long term effects are for the biologic, Q&A: Do you know what the long term effects are for the biologic XOLAIR® (omalizumab) | 39:35 |
| Q&A: Is pregnancy a concern for people with only minor symptoms of Behcets? | 42:12 |
| Q&A: Do you have any suggestions on how to gain weight when managing vasculitis? | 45:07 |
| Q&A: What are concerns with small cell vasculitis? | 47:16 |
This presentation will cover how vasculitis may effect women differently from men including the reproductive life cycle and hormonal impact.
